Acute Symptoms Produced by Hemodialysis: A Review of Their Causes and Associations
1993; Wiley; Volume: 6; Issue: 1 Linguagem: Inglês
10.1111/j.1525-139x.1993.tb00257.x
ISSN1525-139X
AutoresJ. Gary Abuelo, Douglas Shemin, Joseph A. Chazan,
Tópico(s)Muscle and Compartmental Disorders
ResumoSeminars in DialysisVolume 6, Issue 1 p. 59-59 Acute Symptoms Produced by Hemodialysis: A Review of Their Causes and Associations J. Gary Abuelo, Corresponding Author J. Gary Abuelo From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandAddress correspondence to: J. Gary Abuelo, MD, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02902.Search for more papers by this authorDouglas Shemin, Douglas Shemin From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this authorJoseph A. Chazan, Joseph A. Chazan From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this author J. Gary Abuelo, Corresponding Author J. Gary Abuelo From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandAddress correspondence to: J. Gary Abuelo, MD, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02902.Search for more papers by this authorDouglas Shemin, Douglas Shemin From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this authorJoseph A. Chazan, Joseph A. Chazan From the Division of Renal Diseases, Department of Medicine, Rhode Island Hospital, and Brown University School of Medicine, Providence, Rhode IslandSearch for more papers by this author First published: January 1993 https://doi.org/10.1111/j.1525-139X.1993.tb00257.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rosa AA, Fryd DS, Kjellstrand CM: Dialysis symptoms and stabilization in long-term dialysis. Arch Intern Med 140: 804–807, 1980. 2 DeGoulet P, Reach I, Rozenbaum W, Aime F, Devries C, Berger C, Rojas P, Jacobs C, Legrain M: Societe de Nephrologie. Commission Informatique. Programme dialyse-information. VI.—Survie et facteurs de risque. J Urol Nephrol 85: 909–962, 1985. 3 Pollak VE, Charoenpanich R, Robson M, Kant KS: Dialyzer membranes: Syndromes associated with first use and effects of multiple use. Kidney Int 33(Suppl 24): S49–S52, 1988. 4 Levin NW, Kupin WL, Zasuwa G, Venkat KK: Complications during hemodialysis, in Clinical Dialysis, 2nd ed., edited by AR Nissenson, RN Fine, DE. Gentile Norwalk , Appleton and Lange, 1990, pp. 172–201. 5 Parfrey PS, Vavasour HM, Henry S, Bullock M, Gault MH: Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron 50: 121–128, 1988. 6 Benna P, Lacquaniti F, Triolo G, Ferrero P, Bergamasco B: Acute neurologic complications of hemodialysis. Ital J Neurol Sci 2: 53–57, 1981. 7 U.S. Centers for Disease Control: National surveillance of dialysis-associated diseases in the United States, 1989. Contemp Dial Nephrol 12: 10–11, 1991. 8 Blagg CR: Acute complications associated with hemodialysis, in Replacement of Renal Function by Dialysis, 3rd ed., edited by JF. Maher Dordrecht , Kluwer Academic Publishers, 1989, pp. 750–771. 9 Ward MK, Shadforth M, Hill AVL, Kerr DNS: Air embolism during haemodialysis. Br Med J 3: 74–78, 1971. 10 Dunbar EM, Fox R, Watson B, Akrill P: Successful late treatment of venous air embolism with hyperbaric oxygen. Postgrad Med J 66: 469–470, 1990. 11 Gallery ED, Blomfield J, Dixon SF: Acute zinc toxicity in haemodialysis. Br Med J 4: 331–333, 1972. 12 Petrie JJB, Row PG: Dialysis anaemia caused by subacute zinc toxicity. Lancet 1: 1178–1180, 1977. 13 Lyle WH, Payton JE, Hui M: Hemodialysis and copper fever. Lancet 1: 1324–1325, 1976. 14 Manzler AD, Schreiner AW: Copper-induced acute hemolytic anemia. Ann Intern Med 73: 409–412, 1970. 15 Eastwood JB, Phillips ME, Minty P, Gower PE, Curtis JR: Heparin inactivation, acidosis and copper poisoning due to presumed acid contamination of water in a hemodialysis unit. Clin Nephrol 20: 197–201, 1983. 16 Webster JD, Parker TF, Aldrey AC: Acute nickel intoxication by dialysis. Ann Intern Med 92: 631–633, 1980. 17 Mitchell G, Cirksena W, Samaras G, Wax C: Acute fluoride intoxication in hemodialysis patients. Kidney Int 19: 154, 1981. 18 Carlson DJ, Shapiro FL: Methemoglobinemia from well water nitrates: A complication of home dialysis. Ann Intern Med 73: 757–759, 1970. 19 Hoy RH: Accidental systemic exposure to sodium hypochlorite (Clorox) during hemodialysis. Am J Hosp Pharm 38: 1512–1514, 1981. 20 Mion CM, Canaud B, Garred LJ, Stec F, Nguyen QV: Sterile and pyrogen-free bicarbonate dialysate: A necessity for hemodialysis today. Adv Nephrol 19: 275–314, 1990. 21 Vanholder R, Vanhaecke E, Ringoir S: Waterborne Pseudomonas septicemia. ASAIO Trans 36: M215–M216, 1990. 22 Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 36: 107–118, 1990. 23 Bigazzi R, Atti M, Baldari G: High-permeable membranes and hypersensitivity-like reactions: Role of dialysis fluid contamination. Blood Purif 8: 190–198, 1990. 24 Gotloib L, Servadio C: Microampere electrocution during haemodialysis—An unrecognised cause of sudden death. Proc Eur Dial Transplant Assoc 11: 210–213, 1975. 25 Pun KK, Yeung CK, Chan TK: Acute intravascular hemolysis due to accidental formalin intoxication during hemodialysis. Clin Nephrol 21: 188–190, 1984. 26 Ogden DA, Myers LE, Eskelson CD, Ziegler EJ: Iatrogenic administration of formaldehyde to hemodialyzed patients. Proc Dial Transplant Forum 3: 141–146, 1973. 27 Reveillaud RJ, Deschamps A, Aubert PH: Risks of i.v. administration of formaldehyde to hemodialyzed patients. Kidney Int 11: 292–293, 1977. 28 Erkrath KD, Adebahr G, Kloppel A: Lethal intoxication by formalin during dialysis. Z Rechtsmed 87: 233–236, 1981. 29 Rivera-Vazquez AB, Noriega-Sanchez A, Ramirez-Gonzalez R, Martinez-Maldonado M: Acute hypercalcemia in hemodialysis patients: Distinction from “dialysis dementia. Nephron 25: 243–246, 1980. 30 Freeman RM, Lawton RL, Chamberlain MA: Hard-water syndrome. N Engl J Med 276: 1113–1118, 1967. 31 Fortner RW, Nowakowski A, Carter CB, King LH Jr, Knepshield JH: Death due to overheated dialysate during dialysis. Ann Intern Med 73: 443–444, 1970. 32 Berkes SL, Kahn SI, Chazan JA, Garella S: Prolonged hemolysis from overheated dialysate. Ann Intern Med 83: 363–364, 1975. 33 Tielemans CL, Herbaut CR, Geurts JO, Dratwa M: Hemolysis and consumption coagulopathy due to overheated dialysate. Nephron 30: 190–191, 1982. 34 Said R, Quintanilla A, Levin N, Ivanovich P: Acute hemolysis due to profound hypo-osmolality. A complication of hemodialysis. J Dial 1: 447–452, 1977. 35 Dhaene M, Gulbis B, Lietaer N, Gammar N, Thayse C, Ooms HA, Vanherweghem JL: Red blood cell destruction in single-needle dialysis. Clin Nephrol 31: 327–331, 1989. 36 Francos GC, Burke JF Jr, Besarab A, Martinez J, Kirkwood RG, Hummel LA: An unsuspected cause of acute hemolysis during hemodialysis. ASAIO Trans 29: 140–145, 1983. 37 Hombrouckx RO, De Vos J-Y, Larno LA, Vercruysse VM, Verdonck PR, Verhoeven RF: (A)typical symptoms during single needle dialysis. ASAIO Trans 36: M335–M337, 1990. 38 Nickey WA, Chinitz VL, Kim KE, Onesti G, Swartz C: Hypernatremia from water softener malfunction during home dialysis. JAMA 214: 915–916, 1970. 39 Lindner A, Moskovtchenko JF, Traeger J: Accidental mass hypernatremia during hemodialysis. Nephron 9: 99–105, 1972. 40 Shaldon S, Koch KM: Survival and adequacy in long-term hemodialysis. Nephron 59: 353–357, 1991. 41 Deane N, Wineman RJ: Multiple use of hemodialyzers, in Replacement of Renal Function by Dialysis: A Textbook of Dialysis, 3rd ed., edited by JF. Maher Dordrecht , Kluwer Academic Publishers, 1989, pp. 400–416. 42 Gordon SM, Tipple M, Bland LA, Jarvis WR: Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers. JAMA 260: 2077–2081, 1988. 43 Alter MJ, Favero MS, Miller JK, Coleman PJ, Bland LA: Reuse of hemodialyzers. JAMA 260: 2073–2076, 1988. 44 Wagnild JP, McDonald P, Craig WA, Johnson C, Hanley M, Uman SJ, Ramgopal V, Beirne GJ: Pseudomonas aeruginosa bacteremia in a dialysis unit. II. Relationship to reuse of coils. Am J Med 62: 672–676, 1977. 45 Lowry PW, Beck-Sague CM, Bland LA, Aguero SM, Arduino MJ, Minuth AN, Murray RA, Swenson JM, Jarvis WR: Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis 161: 85–90, 1990. 46 Fine A, Churchill D, Gault H, Mathieson G: Fatality due to subclavian dialysis catheter. Nephron 29: 99–100, 1981. 47 Barton BR, Hermann G, Weil R III: Cardiothoracic emergencies associated with subclavian hemodialysis catheters. JAMA 250: 2660–2662, 1983. 48 Sharp KW, Spees EK, Selby LR, Zachary JB, Ernst CB: Diagnosis and management of retroperitoneal hematomas after femoral vein cannulation for hemodialysis. Surgery 95: 90–95, 1984. 49 Uldall PR, Dyck RF, Woods F, Merchant M, Martin GS, Cardella CJ: A subclavian cannula for temporary vascular access for hemodialysis or plasmapheresis. Dial Transplant 8: 963–968, 1979. 50 Daugirdas JT, Ing TS: First-use reactions during hemodialysis: A definition of subtypes. Kidney Int 33(Suppl 14): S37–S43, 1988. 51 Villarroel F, Ciarkowski AA: A survey on hypersensitivity reactions in hemodialysis. Artif Organs 9: 231–238, 1985. 52 Daugirdas JT, Ing TS, Roxe DM, Ivanovich PT, Krumlovsky F, Popli S, McLaughlin MM: Severe anaphylactoid reactions to cuprammonium cellulose hemodialyzers. Arch Intern Med 145: 489–494, 1985. 53 Parnes EL, Shapiro WB: Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer. Kidney Int 40: 1148–1152, 1991. 54 Brunet P, Jaber K, Berland Y, Baz M: Anaphylactoid reactions during hemodialysis and hemofiltration: Role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 14: 444–447, 1992. 55 Vanholder R, Ringoir S: Influence of reuse and of reuse sterilants on the first-use syndrome. Artif Organs 11: 137–139, 1987. 56 Miller KB, Rosenwasser LJ, Bessette JM, Beer DJ, Rocklin RE: Rapid desensitization for desferrioxamine anaphylactic reaction. Lancet 1: 1059, 1981. 57 Abreo K: Use of deferoxamine in the treatment of aluminum overload in dialysis patients. Semin Dial 1: 55–61, 1988. 58 Cases A, Kelly J, Sabater J, Campistol JM, Torras A, Montoliu J, Lopez I, Revert L: Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. Clin Nephrol 29: 176–178, 1988. 59 Bene C, Manzler A, Kranias G: Irreversible ocular toxicity from single “challenge” dose of deferoxamine. Clin Nephrol 31: 45–48, 1989. 60 Ravelli M, Scaroni P, Mombelloni S, Movilli E, Feller P, Apostoli P, De Maria G, Valotti C, Sciuto G, Maiorca R: Acute visual disorders in patients on regular dialysis given desferrioxamine as a test. Nephrol Dial Transplant 5: 945–949, 1990. 61 Hainline B, Adan L, Sullivan J, Solomon G: Increased cerebrospinal fluid aluminum and neurological deterioration following deferoxamine administration in dialysis encephalopathy. Clin Res 34: 597A, 1986. 62 McCauley J, Sorkin MI: Exacerbation of aluminum encephalopathy after treatment with desferrioxamine. Nephrol Dial Transplant 4: 110–114, 1989. 63 GK McEvoy, (ed) Antianemia drugs (20:04), Iron Preparations (20:04.04) Iron-Dextran Complex, American Hospital Formulary Service. Bethesda , American Society of Hospital Pharmacists Inc, 1992, pp. 766–768. 64 Arieff AI: More on the dialysis disequilibrium syndrome. West J Med 151: 74–76, 1989. 65 Keshaviah P, Collins A: Rapid high-efficiency bicarbonate hemodialysis. ASAIO Trans 32: 17–23, 1986. 66 Bosl R, Shideman JR, Meyer RM, Buselmeier TJ, Von Hartitzsch B, Kjellstrand CM: Effects and complications of high efficiency dialysis. Nephron 15: 151–160, 1975. 67 Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM: Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis. ASAIO Trans 36: M637–M639, 1990. 68 Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW: Clinical experience with short-time hemodialysis. Am J Kidney Dis 14: 49–56, 1992. 69 Basile C, Miller JDR, Koles ZJ, Grace M, Ulan RA: The effects of dialysis on brain water and EEG in stable chronic uremia. Am J Kidney Dis 9: 462–469, 1987. 70 Johnson WJ: Optimum dialysate calcium concentration during maintenance hemodialysis. Nephron 17: 241–258, 1976. 71 Cheigh JS, Rubin AL, Stenzel KH, Whitsell JC: Hypocalcemia following bilateral nephrectomy. Urology 2: 121–124, 1973. 72 Olinger GN, Hottenrott C, Mulder DG, Maloney JV Jr, Miller J, Patterson RW, Sullivan SF, Buckberg GD: Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and postoperative hemodialysis. J Thorac Cardiovasc Surg 72: 503–511, 1976. 73 Arem R: Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 18: 103–121, 1989. 74 Grajower MM, Walter L, Albin J: Hypoglycemia in chronic hemodialysis patients: Association with propranolol use. Nephron 26: 126–129, 1980. 75 Rigg GA, Bercu BA: Hypoglycemia—A complication of hemodialysis. N Engl J Med 277: 1139–1140, 1967. 76 Samii K, Ciancioni CH, Rottembourg J, Bisseliches F, Jacobs C: Severe hypoglycaemia due to beta-blocking drugs in haemodialysis patients. Lancet 1: 545–546, 1976. 77 Savdie E, Whitworth JA: Adverse effects of propranolol in a hemodialysis setting. Dial Transplant 2: 805, 1982. 78 Wiegand CF, Davin TD, Raij L, Kjellstrand CM: Severe hypokalemia induced by hemodialysis. Arch Intern Med 141: 167–170, 1981. 79 Daugirdas JT: Dialysis hypotension: A hemodynamic analysis. Kidney Int 39: 233–246, 1991. 80 Henrich WL: Hemodynamic instability during hemodialysis. Kidney Int 30: 605–612, 1986. 81 Rostand SG, Brunzell JD, Cannon RO III, Victor RG: Cardiovascular complications in renal failure. J Am Soc Nephrol 2: 1053–1062, 1991. 82 O'Hare JA, Callaghan NM, Murnaghan DJ: Dialysis encephalopathy. Clinical electroencephalographic and interventional aspects. Medicine (Baltimore) 62: 129–141, 1983. 83 Fraser CL, Arieff AI: Nervous system complications in uremia. Ann Intern Med 109: 143–153, 1988. 84 McCarthy JT, Milliner DS, Johnson WJ: Clinical experience with desferrioxamine in dialysis patients with aluminum toxicity. Q J Med 74: 257–276, 1990. 85 Kleinman KS, Coburn JW: Amyloid syndromes associated with hemodialysis. Kidney Int 35: 567–575, 1989. 86 Rutsky EA, Rostand SG: Pericarditis in end-stage renal disease: Clinical characteristics and management. Semin Dial 2: 25–30, 1989. 87 Schanzer H, Schwartz M, Harrington E, Haimov M: Treatment of ischemia due to “steal” by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg 7: 770–773, 1988. 88 Leonard A, Shapiro FL: Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med 82: 650–658, 1975. 89 Tietjen DP, Moore J Jr, Gouge SF: Hemodialysis-associated acute subdural hematoma. Am J Nephrol 7: 478–481, 1987. 90 Inzelberg R, Neufeld MY, Reider I, Gari P: Non-surgical treatment of subdural hematoma in a hemodialysis patient. Clin Neurol Neurosurg 91: 85–89, 1989. 91 Kimura K, Tabei K, Asano Y, Hosoda S: Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron 53: 201–207, 1989. 92 Zuber M, Steinmann E, Huser B, Ritz R, Thiel G, Brunner F: Incidence of arrhythmias and myocardial ischaemia during haemodialysis and haemofiltration. Nephrol Dial Transplant 4: 632–634, 1989. 93 Fantuzzi S, Caico S, Amatruda O, Cervini P, Abu-Turky H, Baratelli L, Donati D, Gastaldi L: Hemodialysis-associated cardiac arrhythmias: A lower risk with bicarbonate Nephron 58: 196–200, 1991. 94 Nishimura M, Nakanishe T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M, Takahashi H, Yoshimura M: Serum calcium increases the incidence of arrhythmias during acetate hemodialysis. Am J Kidney Dis 19: 149–155, 1992. 95 Dumler F, Zasuwa G, Levin NW: Effect of dialyzer reprocessing methods on complement activation and hemodialyzer-related symptoms. Artif Organs 11: 128–131, 1987. 96 Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25: 653–659, 1984. 97 Roig E, Betriu A, Castaner A, Magrina J, Sanz G, Navarro-Lopez F: Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis. Am J Med 71: 431–434, 1981. 98 Parfrey PS, Harnett JD, Barre PE: The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 2: 2–12, 1991. 99 Pedersen T, Rasmussen K, Cleemann-Rasmussen K: Effect of hemodialysis on cardiac performance and transmural myocardial perfusion. Clin Nephrol 19: 31–36, 1983. 100 Diskin CJ, Salzsieder KH, Solomon RJ, Carvalho JS, Trebbin WM: Electrocardiographic changes following dialysis. Nephron 27: 94–100, 1981. 101 Pochmalicki G, Jan F, Fouchard I, Teiger E, Benmaad A, Buisson C, Boesch C, Rostoker G: L'ischemie myocardique silencieuse au cours de l'hemodialyse des insuffisants renaux chroniques. Rev Med Interne 12: 116–122, 1991. 102 Kremastinos D, Paraskevaidis I, Voudiklari S, Apostolou T, Kyriakides Z, Zirogiannis P, Toutouzas P: Painless myocardial ischemia in chronic hemodialysed patients: A real event Nephron 60: 164–170, 1992. 103 Travis M, Henrich WL: Factors which affect cardiac performance during hemodialysis. Semin Dial 2: 241–245, 1989. 104 Dalal S, Yu AW, Gupta DK, Kar PM, Ing TS, Daugirdas JT: l-Lactate high-efficiency hemodialysis: Hemodynamics, blood gas changes, potassium/phosphorus, and symptoms. Kidney Int 38: 896–903, 1990. 105 Nielson VK: The peripheral nerve function in chronic renal failure: A survey. Acta Med Scand 573: 1–33, 1974. 106 McGee SR: Muscle cramps. Arch Intern Med 150: 511–518, 1990. 107 Jenkins PG, Dreher WH: Dialysis-related muscle cramps: Treatment with hypertonic saline and theory as to etiology. ASAIO Trans 21: 479–482, 1975. 108 Rodrigo F, Shideman J, McHugh R: Osmolality changes during hemodialysis. Ann Int Med 86: 554–561, 1977. 109 Bellinghieri G, Savica V, Mallamace A: Correlation between increased serum and tissue l-carnitine levels and improved muscle symptoms in hemodialysis patients. Am J Clin Nutr 38: 523–531, 1983. 110 Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of l-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38: 912–918, 1990. 111 Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V: Dialyser reprocessing with Renalin. Am J Nephrol 11: 27–31, 1991. 112 Shimizu AG, Taylor DW, Sacket DL, Smith EKM, Barnes CC, Hoda P, Lennox G, Martin J, McNeaney H, Mukherjee J, Uniyal B: Reducing patient morbidity from high-efficiency hemodialysis: A double-blind crossover trial. ASAIO Trans 29: 666–668, 1983. 113 Wilkinson R, Barber SG, Robson V: Cramps, thirst and hypertension in hemodialysis patients—the influence of dialysate sodium concentration. Clin Nephrol 7: 101–105, 1977. 114 Stewart WK, Fleming LW, Manual MA: Muscle cramps during maintenance dialysis. Lancet 1: 1049–1051, 1972. 115 Neal CR, Resnikoff E, Unger AM: Treatment of dialysis-related muscle cramps with hypertonic dextrose. Arch Intern Med 141: 171–173, 1981. 116 Raja RM, Kramer MS, Rosenbaum JL: Use of mannitol in hemodialysis. Dial Transplant 6: 32–40, 1976. 117 Canzanello VJ, Hylander-Rosser B, Sands RE: Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis associated muscle cramps. ASAIO Trans 37: 649–652, 1991. 118 Kaji DM, Ackad A, Nottage WG: Prevention of muscle cramps in hemodialysis patients by quinine sulfate. Lancet 2: 66–67, 1976. 119 Peer G, Blum M, Aviram A: Relief of hemodialysis-induced muscular cramps by nifedipine. Dial Transplant 12: 180–181, 1983. 120 Kolmos JH, Moller S: The epidemiology of febrile reactions in haemodialysis. Acta Med Scand 203: 345–349, 1978. 121 Kantor RJ, Carson LA, Graham DR, Petersen NJ, Favero MS: Outbreak of pyrogenic reactions at a dialysis center—association with infusion of heparinized saline solution. Am J Med 74: 449–456, 1983. 122 Mayer G, Watzke H, Schwarz HP: Endotoxinemia and bacterial contamination of dialysate in patients on chronic intermittent haemodialysis. J Nephrol 3: 173–176, 1989. 123 Neyer U, Woss E, Haller R, Kross R: Headache and EEG changes caused by acetate and bicarbonate dialysis. Acta Med Austriaca 10: 15–23, 1983. 124 Nagai K, Pagel M, Rattazzi T, Vizzo J, Scribner BH: The influence of acetate versus bicarbonate on patient symptomatology during dialysis. Proc Eur Dial Transplant Assoc 16: 122–128, 1979. 125 Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: Results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 40: 714–719, 1991. 126 Bijaphala S, Bell AJ, Bennett CA, Evans SM, Dawborn JK: Comparison of high and low sodium bicarbonate and acetate dialysis in stable chronic hemodialysis patients. Clin Nephrol 23: 179–183, 1985. 127 Cybulsky AVE, Matni A, Hollimby DJ: Effects of high sodium dialysate during maintenance hemodialysis. Nephron 41: 57–61, 1985. 128 Barré PE, Brunelle G, Gascon-Barré M: A randomized double blind trial of dialysate sodiums of 145 mEq/L, 150 mEq/L, and 155 mEq/L. ASAIO Trans 34: 338–341, 1988. 129 Raju SF, White AR, Barnes TT, Smith PP, Kirchner KA: Improvement in disequilibrium symptoms during dialysis with low glucose dialyzate. Clin Nephron 18: 126–129, 1982. 130 Leski M, Niethammer T, Wyss T: Glucose-enriched dialysate and tolerance to maintenance hemodialysis. Nephron 24: 271–273, 1979. 131 Coronel F, Horcajo P, Alvarez MJ, Torrente, J, Rentero R: Sublingual captopril in hypertensive attacks in patients on hemodialysis. Nephron 49: 339–340, 1988. 132 Nieto M, Riambau E, Romay R, Samon J: Crisis hipertensivas en hemodialisis tratadas con nifedipina. Med Clin (Barc) 88: 697, 1987. 133 Hannedouche T, Josse S, Godin M, Fillastre JP: Nifedipine in hemodialyzed patients. Clin Nephrol 23: 319, 1985. 134 Ivanovich P, Chenoweth DE, Schmidt R, Klinkmann H, Boxer LA, Jacob HS, Hammerschmidt DE: Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 24: 758–763, 1983. 135 Buoncristiani U, Giombini L, Cozzari M, Carobi C, Quintaliani G, Brugnano R: Daily recycled bicarbonate dialysis with polyacrylonitrile. ASAIO Trans 29: 669–672, 1983. 136 Van Stone JC, Cook J: The effect of bicarbonate dialysate in stable chronic hemodialysis patients. Dial Transplant 8: 703–709, 1979. 137 Lefebvre A: A hemodialysis bath with bicarbonate improves comfort and ultrafiltration. Nephrologie 4: 200, 1983. 138 Graeffe U, Milutinovich J, Follette WC, Vizzo JE: Less dialysis induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 88: 332–336, 1978. 139 Singhal PC, Lynn RI, Scharschmidt LA: Priapism and dialysis. Am J Nephrol 6: 358–361, 1986. 140 Fassbinder W, Frei U, Issantier R, Koch KM, Mion C, Shaldon S, Slingeneyer A: Factors predisposing to priapism in haemodialysis patients. Proc Eur Dial Transplant Assoc 12: 380–386, 1976. 141 von Hartitzach B, Kerr DN, Morley G, Marks B: Androgens in the anaemia of chronic renal failure. Nephron 18: 13–20, 1977. 142 Branger B, Ramperez P, Oules R, Balducchi JP, Fourcade J, Shaldon S, Costa P, Louis JF, Navratil H: Metaraminol for haemodialysis-associated priapism. Lancet 1: 641, 1985. 143 Osman Y, Poh-Fitzpatrick MB: Dermatologic disorders associated with chronic renal failure. Semin Dial 1: 86–90, 1988. 144 Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA: Ultraviolet phototherapy of uremic pruritus. Ann Intern Med 91: 17–21, 1979. 145 Gupta AK, Gupta MA, Cardella CJ, Haberman HF: Cutaneous associations of chronic renal failure and dialysis. Int J Dermatol 25: 498–504, 1986. 146 Stahle-Backdahl M, Hagermark O, Lins L-E: Pruritus in patients on maintenance hemodialysis. Acta Med Scand 224: 55–60, 1988. 147 Weber M, Schmutz JL: Hemodialysis and the skin. Contrib Nephrol 62: 75–85, 1988. 148 Stahle-Backdahl M, Hagermark O, Lins L-E, Torring O, Hilliges M, Johansson O: Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus. J Intern Med 225: 411–415, 1989. 149 Blachley JD, Blankenship DM, Menter A, Parker TF III, Knochel JP: Uremic pruritus: Skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 5: 237–241, 1985. 150 Hampers CL, Katz AI, Wilson RE, Merrill JP: Disappearance of “uremic” itching after subtotal parathyroidectomy. N Engl J Med 279: 695–697, 1968. 151 Ponticelli C, Bencini PL: Uremic pruritus: A review. Nephron 60: 1–5, 1992. 152 Silverberg DS, Iaina A, Reisin E, Rotzak R, Eliahou HE: Cholestyramine in uraemic pruritus. Br Med J 1: 752–753, 1977. 153 Wrong OM: Cholestyramine in uraemic pruritus. Br Med J 1: 1662, 1977. 154 De Marchi S, Cecchin E, Villalta D, Sepiacci G, Santini G, Bartoli E: Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. New Engl J Med 326: 969–974, 1992. 155 Pederson JA, Matter BJ, Czerwinski AW, Llach F: Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med 93: 446–448, 1980. 156 Yatzidis H, Digenis P, Tountas C: Heparin treatment of uremic itching. JAMA 222: 1183–1184, 1972. 157 Graf H, Kovarik J, Stummvoll HK, Wolf A: Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J 2: 1478–1479, 1979. 158 Breneman DL, Cardone JS, Blumsack RF, Lather RM, Searle EA, Pollack VE: Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 26: 91–94, 1992. 159 Callaghan N: Restless leg syndrome in uremic neuropathy. Neurology 16: 359–361, 1966. 160 Roger SD, Harris DCH, Stewart JH: Possible relation between restless legs and anaemia in renal dialysis patients. Lancet 337: 1551, 1991. 161 Bastani B, Westervelt FB: Effectiveness of clonidine in alleviating the symptoms of “restless legs. Am J Kidney Dis 10: 326–327, 1987. 162 Fraser CL, Arieff AI: Nervous system complications in uremia. Ann Intern Med 109: 143–153, 1988. 163 Savazzi GM: Pathogenesis of cerebral atrophy in uremia. Nephron 49: 94–103, 1988. 164 Nissenson AR, Marsh JT, Brown WS: Central nervous system function in dialysis patients: A practical approach. Semin Dial 4: 115–123, 1991. 165 Josse S, Godin M, Fillastre JP: Cefazolin-induced encephalopathy in a uraemic patient. Nephron 45: 72, 1987. 166 Horton MW, Byerly WG: Practical guidelines for drug therapy in dialysis: Opioid analgesics. Semin Dial 3: 187–191, 1990. 167 Edmunds ME, Walls J: Pathogenesis of seizures during recombinant human erythropoietin therapy. Semin Dial 4: 163–166, 1991. 168 Raskin NH, Fishman RA: Neurologic disorders in renal failure. N Engl J Med 294: 143–148, 204–210, 1976. 169 Santiago A, Chazan JA: The cause of death and co-morbid factors in 405 chronic hemodialysis patients. Dial Transplant 18: 484–488, 1989. 170 Sforzini, Latini R, Mingardi G, Vincenti A, Redaelli B: Ventricular arrhythmias and four-year mortality in haemodialysis patients. Lancet 339: 212–213, 1992. 171 Chazan JA, Pono LM: Sudden death in patients with chronic renal failure on hemodialysis. Dial Transplant 16: 447–448, 1987. 172 D'Elia JA, Weinrauch LA, Gleason RE, Hampton LA, Smith-Ossman S, Yoburn DC, Kaldany A, Healy RW, Leland OS Jr: Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med 148: 2381–2385, 1988. 173 Chazan JA, Pono L, Linhares KB: The impact of advanced life support training for nursing personnel in an outpatient renal dialysis center. RI Med J 67: 503, 1984. 174 Lundin AP, Stein RA, Brown CD, LaBelle P, Kalman FS, Delano BG, Heneghan WF, Lazarus NA, Krasnow N, Friedman EA: Fatigue, acid-base and electrolyte changes with exhaustive treadmill exercise in hemodialysis patients. Nephron 46: 57–62, 1987. 175 Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 300: 573–578, 1990. 176 Barton CH, Vaziri ND: Central retinal vein occlusion associated with hemodialysis. Am J Med Sci 277: 39–47, 1979. 177 Arora N, Lambrou FH Jr, Stewart MW, Vidrine-Parks L, Sandroni S: Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron 59: 490–492, 1991. 178 Servilla KS, Groggel GC: Anterior ischemic optic neuropathy as a complication of hemodialysis. Am J Kidney Dis 8: 61–63, 1986. 179 Jaeger P, Morisod L, Wauters JP, Faggioni R: Prevention of glaucoma during hemodialysis by mannitol and acetazolamide. N Engl J Med 303: 702, 1980. 180 Costagliola C, Mastropasqua L: The influence of hemodialysis on intraocular pressure. III. Aqueous humor dynamics and tissue hydration. Ann Ophthalmol 23: 31–34, 1991. Citing Literature Volume6, Issue1January 1993Pages 59-59 ReferencesRelatedInformation
Referência(s)